| Net Loss | -10.92K |
| Amortization | |
| Donated services | 0 |
| Impairment loss | |
| Shares issued for services | |
| Options expense | |
| Amortization of deferred compensation | |
| Gain on settlement of accounts payable | -666 |
| Gain on change in fair value of derivative liability | |
| Write-off of intellectual property | |
| Accounts receivable | |
| Prepaid expenses | |
| Accounts payable and accrued liabilities | -13.67K |
| Net cash used in operating activities | -24.89K |
| Patent protection costs | |
| Advances to related parties | |
| Collection of advances to related parties | |
| Purchase of equipment | |
| Net cash used in investing activities | |
| Advances from related parties | |
| Bank indebtedness | |
| Proceeds from convertible debentures | |
| Proceeds from the exercise of options | |
| Proceeds from the sale of common stock | |
| Net cash provided by financing activities | 24.86K |
| Net increase (decrease) in cash and cash equivalents | -32 |
| Cash and cash equivalents, beginning of period | 42 |
| Cash and cash equivalents, end of period | 10 |
| Interest paid | 0 |
| Income tax paid | |
| Cumulative effect of change in accounting principle | |
| Warrants issued for equity line of credit | |
| Shares issued to settle debt | |
| Shares issued for convertible debenture | |
| Shares issued for intellectual property | |
| Affiliate's shares issued for intellectual property | |